Biliary Atresia Registry

ASSERT – A Phase 3 double-blind, randomized, Placebo-controlled study of the safety and efficacy of Odevixibat (A4250) in patients with Alagille syndrome

BOLD – A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficiacy and Safety of Odevixibat (A4250) in Children With Biliary Atresia Who Have Undergone a Kasai Hepatoenterostomy

A4250 in paediatric cholestasis